Beste ASCO podcaster (2023)

A

ASCO Daily News

1
What the FDA CAR T-Cell Therapy Investigation Means for Oncologists 17:26

12h ago17:26

17:26

Drs. John Sweetenham and Fred Locke discuss the FDA investigation on the risk of cancer from CAR T-cell therapy and share insights on the known number of cases and the potential implications on clinical research and patient care. TRANSCRIPT Dr. John Sweetenham: Hello, I’m Dr. John Sweetenham from the UT Southwestern Harold C. Simmons Comprehensive …

A

ASCO Daily News

1
Managing the Complexities of Oncology Practice in 2024 26:19

21h ago26:19

26:19

Drs. John Sweetenham and Lawrence Shulman discuss the challenges that oncologists will be confronting in 2024 and share insights on how to build clinician resilience and optimize the oncology workforce to provide better, safer care for patients with cancer. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham from the UT Southwestern Haro…

A

ASCO Daily News

1
Solutions and Key Research to Advance High-Quality Cancer Care 17:41

29d ago17:41

17:41

Drs. Cardinale Smith and Raymond Osarogiagbon discuss key research featured at the 2023 ASCO Quality Care Symposium, including the role of AI in quality measurement and solution-focused approaches addressing care delivery, financial toxicity, and clinician well-being. TRANSCRIPT Dr. Raymond Osarogiagbon: Hello. I'm Dr. Raymond Osarogiagbon, your gu…

A

ASCO Guidelines

1
Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update 9:56

1M ago9:56

9:56

Dr. Rohan Garje reviews the latest rapid recommendation update for the ASCO guideline on systemic therapy in men with metastatic castration-resistant prostate cancer (mCRPC). He reviews what prompted the guideline update and the latest recommendation from the expert panel. Dr. Garje also discusses future updates to the guideline that are currently …

A

ASCO Daily News

1
How to Implement Universal Germline Testing for CRC 15:16

1M ago15:16

15:16

Drs. Shaalan Beg and Priyanka Kanth discuss the readiness, logistics, and barriers to implementing universal germline multigene panel testing for colorectal cancer (CRC) following new guidelines from the National Comprehensive Cancer Network that recommend genomic testing for all individuals with CRC younger than age 50. The experts also address ot…

A

ASCO Daily News

1
Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy 28:25

2M ago28:25

28:25

Drs. Diwakar Davar and Ben Boursi discuss the role of the gut microbiome in the outcome of cancer immunotherapy and the prevention of immunotherapy-related adverse events, as well as compelling research on nutritional interventions to improve response to immune checkpoint inhibitors. TRANSCRIPT Dr. Diwakar Davar: Hello, and welcome to the ASCO Dail…

A

ASCO Guidelines

1
Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline 27:13

2M ago27:13

27:13

Dr. Greg Kalemkerian joins us on the ASCO Guideline Podcast to discuss the newest ASCO – Ontario Health (Cancer Care Ontario) Guideline on systemic therapy for small-cell lung cancer (SCLC). He reviews the evidence-based recommendations from the panel, including guidance on systemic therapy options for resected, limited-stage, extensive-stage, and …

A

ASCO Education

1
Cancer Topics - Oncology Practice in Low-Resource Settings 39:11

2M ago39:11

39:11

Resources such as facilities, equipment, medications, and trained healthcare professionals are essential to provide proper care. Yet, many areas in the US and around the globe have challenges providing some of such resources. This ASCO Education podcast will explore oncology practice in low resource settings. Dr. Thierry Alcindor, a medical oncolog…

A

ASCO Guidelines

1
Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update 7:48

2M ago7:48

7:48

Dr. Eric Singer highlights the recent rapid recommendation update from ASCO on the management of metastatic renal cell cancer (ccRCC), based on the review of evidence from the phase III COSMIC 313 trial. Dr. Singer reviews the discussion from the Expert Panel and emphasizes clinicians should continue to follow the previously issued recommendations …

A

ASCO Guidelines

1
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs Guideline 18:47

2M ago18:47

18:47

Dr. Jaydira Del Rivero and Dr. Kimberly Perez discuss the latest ASCO guideline featuring evidence-based recommendations on systemic therapy for well-differentiated grade 1 to grade 3 metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). They discuss the recommendations, insights from the guideline expert panel, impact for clinicians …

A

ASCO Daily News

1
Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer 30:39

2M ago30:39

30:39

Drs. Hope Rugo and Nancy Davidson discuss the next generation of endocrine therapy in hormone receptor-positive breast cancer – SERDs, SERMs, CERANs, and PROTACs – and challenges relating to the optimal sequence of therapeutic options. TRANSCRIPT Dr. Hope Rugo: Hello, I'm Dr. Hope Rugo, your guest host of the ASCO Daily News Podcast today. I'm a pr…

A

ASCO Education

1
Cancer Topics - Oncology Practice In Rural Settings Part 2 22:04

3M ago22:04

22:04

People who live in major cities in the US and abroad tend to benefit from better cancer care due to having access to more doctors, facilities and equipment. In contrast, those who live in rural areas face many challenges accessing consistent and quality care. In Part Two of this ASCO Education Podcast Dr. Jack Hensold, a hematologist/oncologist in …

A

ASCO Guidelines

1
Systemic Therapy for Melanoma Guideline Update 16:35

3M ago16:35

16:35

Dr. Michael Atkins and Dr. Vernon Sondak highlight the latest updates to the systemic therapy for melanoma recommendations in this newest guideline. The discussion covers neoadjuvant and adjuvant therapy for resected cutaneous melanoma, options for unresectable and/or metastatic cutaneous melanoma, and therapies for noncutaneous melanoma. They revi…

A

ASCO Education

1
Oncology, Etc. – Dr. Patricia Ganz’ Evolutionary Treatment Of The Whole Patient 35:39

3M ago35:39

35:39

There was time during the early 70’s when the field of oncology began to take hold where the singular focus was to extend the patient’s life. In this ASCO Education podcast, our guest was one of the first to challenge that notion and rethink methods that focused the patient’s QUALITY of life. Dr. Patricia Ganz joins us to describe her transition fr…

A

ASCO Daily News

1
ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care 19:43

4M ago19:43

19:43

Drs. Lillian Siu and Melvin Chua discuss scientific innovations, disruptive technologies, and novel ways to practice oncology that were featured at the 2023 ASCO Breakthrough meeting in Yokohama, Japan, including CRISPR and gene editing, CAR T-cell and adoptive cell therapies, as well as emerging AI applications that are poised to revolutionize can…

A

ASCO Education

1
Cancer Topics – ICC Program Malaysia 22:35

4M ago22:35

22:35

Providing high-quality cancer care to patients is the goal for any oncologist, yet there are many places across the globe that face multiple hurdles in achieving that goal. In this ASCO Education podcast we explore how one group is making a positive impact in the state of Surawak in Malaysia via the efforts of ASCO’s International Cancer Corp Progr…

A

ASCO Guidelines

1
Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: SIO-ASCO Guideline 14:22

4M ago14:22

14:22

Dr. Julia Rowland shares the newest evidence-based recommendations from SIO and ASCO on integrative therapies for managing anxiety and depression symptoms in adults with cancer. Listen in to hear recommended options, such as acupuncture, aromatherapy, hypnosis, mindfulness, music therapy, relaxation, reflexology, Tai Chi and/or Qigong, and yoga. Dr…

A

ASCO Daily News

1
How Oncologists Are Confronting the Cancer Drug Shortage 25:17

4M ago25:17

25:17

Drs. Vamsi Velcheti, Taofeek Owonikoko, and Janakiraman Subramanian discuss their experiences navigating the cancer drug shortage in the United States, the impact on patients and clinical trial enrollment, lessons learned, and proactive strategies to mitigate future crises. TRANSCRIPT Dr. Vamsi Velcheti: Hello, I'm Dr. Vamsi Velcheti, your guest ho…

A

ASCO Education

1
Oncology, Etc. – The Diversity Mission with Dr Edith Mitchell 25:38

4M ago25:38

25:38

Increasing diversity in the field of oncology is an ongoing task. Our next guest has made it her mission to increase those ranks as well as becoming the first African American woman to be a Brigadier General in the US Air Force. Dr. Edith Mitchell describes her early years growing up in rural Tennessee (2:52), the motivation for joining the Air For…

A

ASCO Daily News

1
AI Will Allow Doctors to Reclaim Time With Patients 19:47

4M ago19:47

19:47

Drs. Douglas Flora and Shaalan Beg discuss the use of artificial intelligence in oncology, its potential to revolutionize cancer care, from early detection to precision medicine, and its limitations in some aspects of care. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, your guest host of the podc…

A

ASCO Daily News

1
Managing the Side Effects of Endocrine Therapy for Breast Cancer 29:12

4M ago29:12

29:12

Drs. Hope Rugo and Kristin Rojas discuss advances in the management of menopausal symptoms, fertility preservation, and bone health for women on endocrine therapy for breast cancer. TRANSCRIPT Dr. Hope Rugo: Hello. I'm Dr. Hope Rugo, your guest host of the ASCO Daily News Podcast today. I'm a professor of medicine and director of breast oncology an…

A

ASCO Guidelines

1
Management of Stage III NSCLC Rapid Recommendation Update 8:14

5M ago8:14

8:14

Dr. Navneet Singh joins us again, this time to discuss the rapid recommendation update for stage III non-small cell lung cancer, incorporating updated data presented at the 2023 ASCO Annual Meeting. He discusses the new trials that prompted the guideline update and updated recommendations on adjuvant osimertinib for patients with EGFR exon 19 delet…

A

ASCO Education

1
Cancer Topics – Research to Practice: Prostate Cancer (Part 2) 31:09

5M ago31:09

31:09

In this episode of ASCO Educational podcasts, we'll explore how we interpret and integrate recently reported clinical research into practice. Part One involved a 72-year old man with high-risk, localized prostate cancer progressing to hormone-sensitive metastatic disease. Today’s scenario focuses on de novo metastatic prostate cancer. Our guests ar…

A

ASCO Guidelines

1
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update 23:09

5M ago23:09

23:09

Dr. Supriya Mohile , Dr. William Dale, and Dr. Heidi Klepin discuss the updated guideline on the practical assessment and management of age-associated vulnerabilities in older patients undergoing systemic cancer therapy. They highlight recent evidence that prompted the guideline update, and share the updated evidence-based recommendations from the …

A

ASCO Daily News

1
The Emergence of Triplet Therapies in ccRCC in the Frontline Setting 22:46

5M ago22:46

22:46

Drs. Pedro Barata and Naomi Haas discuss the emergence of clinical trials investigating triplet combinations in advanced renal cell carcinoma, factors that influence treatment decisions, strategies to personalize therapies in the frontline setting, including response-adaptive treatment strategies, and the use of biomarkers such as gene expression a…

A

ASCO Guidelines

1
Cancer Cachexia Rapid Recommendation Update 8:55

5M ago8:55

8:55

Dr. Charles Loprinzi shares the latest update to the management of cancer cachexia guideline. Dr. Loprinzi discusses the evidence that prompted the rapid update to the guideline and reviews the new evidence-based recommendations, including the addition of low-dose olanzapine as a treatment option for patients with advanced cancer to improve weight …

A

ASCO Guidelines

1
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2 7:30

5M ago7:30

7:30

Dr. Navneet Singh highlights the latest evidence-based recommendation updates from the ASCO living guideline on stage IV non-small cell lung cancer with driver alterations. This update focuses on new second-line options for patients with advanced NSCLC and an EGFR exon 20 insertion, including amivantamab and mobocertinib. Dr. Singh also discusses u…

A

ASCO Education

1
Oncology, Etc. – Dr. Lori Pierce’s Path From Engineering To Oncology 40:09

5M ago40:09

40:09

There are many treatments available for cancer but how do you make csre delivery equitable? Given the various types of cancers how can you allocate the right resources to create equal outcomes? Dr. Lori Pierce has made equity a primary focus of her career. She describes how physics and radiology inspired her to be an engineer (6:06), and the moment…

A

ASCO Daily News

1
Novel Therapies in GI Oncology at ASCO23 18:30

5M ago18:30

18:30

Drs. Shaalan Beg and Shiraj Sen discuss notable advances in GI cancers featured at the 2023 ASCO Annual Meeting, including the PROSPECT and PRODIGE-23 trials in rectal adenocarcinoma, the MORPHEUS study in uHCC, and the NORPACT-1 trial in pancreatic head cancer. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. …

A

ASCO Daily News

1
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23 23:25

5M ago23:25

23:25

Drs. Rana McKay and Jonathan Rosenberg highlight key advances in genitourinary cancers featured at the 2023 ASCO Annual Meeting, including the THOR study in mUCC, VESPER in muscle-invasive bladder cancer, CONTACT-03 in mRCC, and TALAPRO-2 in mCRPC. TRANSCRIPT Dr. Rana McKay: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Rana McKay, you…

A

ASCO Daily News

1
Spotlight on Immunotherapy at ASCO23 34:23

5M ago34:23

34:23

Drs. Diwakar Davar and Jason Luke discuss KEYNOTE-716, KEYNOTE-942, RELATIVITY-047, and other key advances in melanoma, including the promise of mRNA vaccines in melanoma and potentially other cancers, as well exciting advances in neoadjuvant therapies across malignancies featured at the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Diwakar Davar: Hello…

A

ASCO Daily News

1
Highlights in Hematologic Malignancies at ASCO23  18:10

6M ago18:10

18:10

Drs. John Sweetenham and Marc Braunstein discuss advances in hematologic malignancies featured at the 2023 ASCO Annual Meeting, including the potentially practice-changing SWOG-S1826 study in Hodgkin lymphoma, the promise of bispecific antibodies in B-cell malignancies, and a novel approach to deliver vital anti-myeloma medications that could impro…

A

ASCO Daily News

1
ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23 31:09

6M ago31:09

31:09

Drs. Vamsi Velcheti and Jack West discuss ADAURA, KEYNOTE-671, and KEYNOTE-789 trials in NSCLC and the first pivotal study of sunvozertinib for the treatment of NSCLC with EGFR exon 20 insertion mutations. TRANSCRIPT Dr. Vamsi Velcheti: Hello, I'm Dr. Vamsi Velcheti, your guest host for the ASCO Daily News Podcast. I'm a professor of medicine and d…

A

ASCO Daily News

1
SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23 25:11

6M ago25:11

25:11

Drs. Allison Zibelli and Arielle Heeke discuss the NATALEE trial’s novel approach to high-risk HR+ breast cancer, the potential of delaying CDK4/6 inhibitors in HR+, HER2-negative mBC to decrease toxicities and costs in the SONIA trial, and de-escalation strategies in HER2+ early-stage breast cancer. TRANSCRIPT Dr. Allison Zibelli: Hello. I'm Dr. A…

A

ASCO Education

1
Cancer Topics - Oncology Practice In Rural Settings Part 1 28:27

6M ago28:27

28:27

People who live in major cities in the US and abroad tend to benefit from better cancer care due to having access to more doctors, facilities and equipment. In contrast, those who live in rural areas face many challenges accessing consistent and quality care. In Part One of this ASCO Education Podcast Dr. Jack Hensold, a hematologist/oncologist in …

A

ASCO Education

1
Oncology, Etc. – Pioneering Geriatric Cancer Care with Dr. Hyman Muss 31:27

6M ago31:27

31:27

Age is a main factor when determining cancer care. In this ASCO Education podcast we speak to one of the top leaders in treatment for older patients who has also credited mentorship as a foundation for his career. Dr. Hyman Muss describes his childhood in Brooklyn, serving as a general physician for troops in Vietnam (6:18), the doctor who influenc…

A

ASCO Daily News

1
Addressing the Impact of Prior Authorization on Access to Cancer Treatment 25:13

6M ago25:13

25:13

Drs. Nathan Pennell and Nancy Lin discuss emerging data on the growing problem of prior authorization and insurance denials in cancer care, their potentially harmful impact on patient outcomes, and what can be done to fix the problem. TRANSCRIPT Dr. Nathan Pennell: Hello, I'm Dr. Nathan Pennell, your guest host for the ASCO Daily News Podcast today…

A

ASCO Guidelines

1
HER2 Testing in Breast Cancer: ASCO-CAP Guideline Update 24:56

6M ago24:56

24:56

Dr. Antonio Wolff and Dr. Kim Allison discuss the latest ASCO-CAP guideline update on HER2 testing in breast cancer. This guideline update affirms previous recommendations, and provides commentary based on data from the DESTINY-Breast04 trial. Dr. Wolff and Dr. Allison review the questions from the oncology and pathology community raised by these r…

A

ASCO Daily News

1
ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy 28:57

7M ago28:57

28:57

Dr. Diwakar Davar and Dr. Jason Luke discuss advances in melanoma, including targeted therapy and the addition of LAG-3 inhibitors to checkpoint therapy, as well as promising checkpoint inhibitors in cutaneous squamous cell carcinoma and Merkel cell carcinoma in advance of the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Diwakar Davar: Hello, and welco…

A

ASCO Daily News

1
ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies 23:38

7M ago23:38

23:38

Dr. John Sweetenham and Dr. Marc Braunstein discuss the role of maintenance therapy in high-risk multiple myeloma, advances in myelodysplastic syndromes in the COMMANDS study, the promise of bispecific antibodies in the pivotal EPCORE NHL-1 in relapsed/refractory large B-cell lymphoma, and improving outcomes for patients with chronic lymphocytic le…

A

ASCO Daily News

1
ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer 24:49

7M ago24:49

24:49

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss the CLEAR study in renal cell carcinoma, a new exploratory analysis combining the TheraP and VISION trials in metastatic urothelial cancer, and compelling advances in prostate cancer and across GU oncology in advance of the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Neeraj Agarwal: Hello and welc…

A

ASCO Daily News

1
ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers 21:45

7M ago21:45

21:45

Dr. Shaalan Beg and Dr. Mohamed Salem discuss novel therapies in gastrointestinal cancers, including CAR T therapy and the CodeBreak-101 trial in mCRC, new advances in uHCC in the HIMALAYA trial, and an exciting update from the NAPOLI-3 trial in pancreatic cancer, ahead of the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome…

A

ASCO Daily News

1
ASCO23: Novel Therapies in Lung Cancer  22:53

7M ago22:53

22:53

Drs. Vamsi Velcheti and Jack West discuss key abstracts in advanced SCLC and NSCLC, along with highlighting the largest known data set correlating ctDNA levels and efficacy outcomes in the EMPOWER-Lung 1 trial, in advance of the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Vamsidhar Velcheti: Hello, I am Dr. Vamsidhar Velcheti, your guest host of the A…

A

ASCO Daily News

1
ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer 19:49

7M ago19:49

19:49

Dr. Allison Zibelli and Dr. Megan Kruse highlight the PALMIRA and LEONARDA-1 trials, a new standard of care in the treatment of hand-foot syndrome for patients receiving capecitabine, and other key breast cancer studies that will be featured at the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. Allison Zibelli: Hello. I'm Dr. Allison Zibelli, your host f…

A

ASCO Daily News

1
ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities 20:54

7M ago20:54

20:54

Dr. John Sweetenham and Dr. Neeraj Agarwal discuss advances across the spectrum of malignancies, including key studies in precision oncology and disparities in cancer care in advance of the 2023 ASCO Annual Meeting. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham, now the associate director for cancer network clinical affairs at UT S…

A

ASCO Education

1
Cancer Topics – Alternative to 10-Year ABIM MOC Exam: Longitudinal Knowledge Assessment 10:35

7M ago10:35

10:35

To stay up to date with new treatments and standards of care medical oncologists in the United States are required to take the ABIM Maintenance of Certification exam, a ten-hour test, every ten years. This ASCO education podcast focuses on the Longitudinal Knowledge Assessment. An alternative test that offers more flexibility in medical certificati…

A

ASCO Guidelines

1
Testing for ESR1 Mutations to Guide Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Rapid Recommendation Update 10:42

7M ago10:42

10:42

Dr. Angie DeMichele and Dr. Lynn Henry present the latest rapid recommendation impacting two ASCO guidelines. This update focuses on testing for ESR1 mutations in patients with hormone receptor-positive, HER2-negative metastatic breast cancer, and presents treatment recommendations for patients with a detectable ESR1 mutation. Dr. DeMichele and Dr.…

B

Buon ascolto

1
Bonus track: seguitemi! 0:47

7M ago0:47

0:47

Meno di un minuto per invitarvi a seguire il mio nuovo podcast, facciamo spazio. Tutti i link per seguire facciamo spazio sulle varie piattaforme li trovate qui: https://pod.link/facciamospazio Hosted on Acast. See acast.com/privacy for more information.Av Giada Centofanti

A

ASCO Education

1
Cancer Topics – Research to Practice: Prostate Cancer (Part 1) 27:13

7M ago27:13

27:13

In this episode of ASCO Educational podcasts, we'll explore how we interpret and integrate recently reported clinical research into practice. The first scenario involves a 72-year old man with high-risk, localized prostate cancer progressing to hormone-sensitive metastatic disease. Our guests are Dr. Kriti Mittal (UMass Chan Medical School) and Dr.…

A

ASCO Education

1
Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick 29:34

7M ago29:34

29:34

The early 1970’s saw the start of the medical specialty we now know as oncology. How does one create standards and practices for patient care during that time? Dr. John Glick is a pioneer during the dawn of oncology. He says that early work involved humanity, optimism, and compassion, all of which were the foundation of his career. Dr Glick describ…

Podcaster verdt å lytte til

ASCO Podcaster

Podcaster verdt å lytte til

Hurtigreferanseguide